Just need confirmation of PaaS and to a much lesser extent FDA approval. I feel FDA approval wont amount to much without PaaS sorted (in the short term).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
